Cargando…

Impact of L-ornithine L-aspartate on non-alcoholic steatohepatitis-associated hyperammonemia and muscle alterations

BACKGROUND: Metabolic dysfunction-associated fatty liver disease (MAFLD) is the most common chronic liver disease in the world. Progression toward non-alcoholic steatohepatitis (NASH) is associated with alterations of skeletal muscle. One plausible mechanism for altered muscle compartment in liver d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pichon, Camille, Nachit, Maxime, Gillard, Justine, Vande Velde, Greetje, Lanthier, Nicolas, Leclercq, Isabelle A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Nutrition
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709200/ https://www.ncbi.nlm.nih.gov/pubmed/36466421 http://dx.doi.org/10.3389/fnut.2022.1051157

Ejemplares similares

Myosteatosis rather than sarcopenia associates with non‐alcoholic steatohepatitis in non‐alcoholic fatty liver disease preclinical models
por: Nachit, Maxime, et al.
Publicado: (2020)

Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
por: Gillard, Justine, et al.
Publicado: (2021)

l-Ornithine l-Aspartate (LOLA) as a Novel Approach for Therapy of Non-alcoholic Fatty Liver Disease
por: Canbay, Ali, et al.
Publicado: (2019)

Pharmacokinetic and Pharmacodynamic Properties of l-Ornithine l-Aspartate (LOLA) in Hepatic Encephalopathy
por: Kircheis, Gerald, et al.
Publicado: (2019)

Effect of l-ornithine l-aspartate against thioacetamide-induced hepatic damage in rats
por: Najmi, Abul K., et al.
Publicado: (2010)

Hyperammonemic hepatic encephalopathy management through L-ornithin-L-aspartate administration in dogs
por: Ahn, Jin-Ok, et al.
Publicado: (2016)

Hyperammonemia in a Patient with Late-Onset Ornithine Carbamoyltransferase Deficiency
por: Choi, Dae Eun, et al.
Publicado: (2012)

Hyperammonemia in a Woman with Late-onset Ornithine Transcarbamylase Deficiency
por: Koya, Yudai, et al.
Publicado: (2018)

Oral Intake of L-Ornithine-L-Aspartate Is Associated with Distinct Microbiome and Metabolome Changes in Cirrhosis
por: Horvath, Angela, et al.
Publicado: (2022)

Late-Onset Ornithine Carbamoyltransferase Deficiency Accompanying Acute Pancreatitis and Hyperammonemia
por: Machado, Marcel Cerqueira Cesar, et al.
Publicado: (2013)

Pharmacologic rescue of hyperammonemia-induced toxicity in zebrafish by inhibition of ornithine aminotransferase
por: Zielonka, Matthias, et al.
Publicado: (2018)

L-Ornithine L-Aspartate for the Treatment of Sarcopenia in Chronic Liver Disease: The Taming of a Vicious Cycle
por: Butterworth, Roger F.
Publicado: (2019)

Fetuin-A in Activated Liver Macrophages Is a Key Feature of Non-Alcoholic Steatohepatitis
por: Etienne, Quentin, et al.
Publicado: (2022)

Severe Hyperammonemia in Late-Onset Ornithine Transcarbamylase Deficiency Triggered by Steroid Administration
por: Gascon-Bayarri, Jordi, et al.
Publicado: (2015)

A novel mutation in ornithine transcarbamylase gene causing mild intermittent hyperammonemia
por: Mohamed, Sarar, et al.
Publicado: (2015)

Hyperammonemia crisis following parturition in a female patient with ornithine transcarbamylase deficiency
por: Kido, Jun, et al.
Publicado: (2017)

Psychological Stress Triggers a Hyperammonemia Episode in Patient with Ornithine Transcarbamylase Deficiency
por: Fernández-Elías, Valentín Emilio, et al.
Publicado: (2022)

Effect of Rifaximin, Probiotics, and l-Ornithine l-Aspartate on Minimal Hepatic Encephalopathy: A Randomized Controlled Trial
por: Sharma, Kapil, et al.
Publicado: (2014)

l-Ornithine l-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses
por: Butterworth, Roger F., et al.
Publicado: (2019)

L-Ornithine L-Aspartate Restores Mitochondrial Function and Modulates Intracellular Calcium Homeostasis in Parkinson’s Disease Models
por: Sisalli, Maria Josè, et al.
Publicado: (2022)

Bipolar Membrane Electrodialysis for Direct Conversion of L-Ornithine Monohydrochloride to L-Ornithine
por: He, Jinfeng, et al.
Publicado: (2023)

Clinical impacts of the concomitant use of L-asparaginase and total parenteral nutrition containing L-aspartic acid in patients with acute lymphoblastic leukemia
por: Ko, Minoh, et al.
Publicado: (2023)

A neonate with ornithine aminotransferase deficiency; insights on the hyperammonemia-associated biochemical phenotype of gyrate atrophy()
por: Kaczmarczyk, Aneta, et al.
Publicado: (2022)

Biological tuners to reshape the bile acid pool for therapeutic purposes in non-alcoholic fatty liver disease
por: Gillard, Justine, et al.
Publicado: (2023)

Beneficial effects of L-ornithine L-aspartate for prevention of overt hepatic encephalopathy in patients with cirrhosis: a systematic review with meta-analysis
por: Butterworth, Roger F.
Publicado: (2019)

Rationale of adding muscle volume to muscle fat infiltration in the definition of an adverse muscle composition is unclear
por: Nachit, Maxime, et al.
Publicado: (2021)

Acute treatment of hyperammonemia by continuous renal replacement therapy in a newborn patient with ornithine transcarbamylase deficiency
por: Kim, Hyo Jeong, et al.
Publicado: (2011)

Neurobehavioral dysfunction in non-alcoholic steatohepatitis is associated with hyperammonemia, gut dysbiosis, and metabolic and functional brain regional deficits
por: Higarza, Sara G., et al.
Publicado: (2019)

Dietary fatty acids and risk of non-alcoholic steatohepatitis: A national study in the United States
por: Lu, Xiao-Ting, et al.
Publicado: (2022)

Carvacrol Arrests the Proliferation of Hypopharyngeal Carcinoma Cells by Suppressing Ornithine Decarboxylase and Hyaluronidase Activities
por: Fatima, Kaneez, et al.
Publicado: (2022)

A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy
por: Grover, Vijay P. B., et al.
Publicado: (2016)

Ammonia Scavenger Restores Liver and Muscle Injury in a Mouse Model of Non-alcoholic Steatohepatitis With Sarcopenic Obesity
por: Wang, Zi-Xuan, et al.
Publicado: (2022)

Gypenosides ameliorate high-fat diet-induced non-alcoholic steatohepatitis via farnesoid X receptor activation
por: Li, Hongshan, et al.
Publicado: (2022)

AdipoRon enhances healthspan in middle‐aged obese mice: striking alleviation of myosteatosis and muscle degenerative markers
por: Selvais, Camille M., et al.
Publicado: (2022)

An Intractable Case of Anti-N-methyl-D-aspartate Receptor Encephalitis with Prolonged Hyperammonemia
por: Verma, Rajesh, et al.
Publicado: (2022)

Luteolin alleviates methionine–choline-deficient diet-induced non-alcoholic steatohepatitis by modulating host serum metabolome and gut microbiome
por: Guo, Wei, et al.
Publicado: (2022)

Synthesis of L-Ornithine- and L-Glutamine-Linked PLGAs as Biodegradable Polymers
por: Taşkor Önel, Gülce
Publicado: (2023)

Ornithine α-Ketoglutarate Alleviates Inflammation via Regulating Ileal Mucosa Microbiota and Metabolites in Enterotoxigenic Escherichia coli-Infected Pigs
por: Li, Yuying, et al.
Publicado: (2022)

L-Ornithine Derived Polyamines in Cystic Fibrosis Airways
por: Grasemann, Hartmut, et al.
Publicado: (2012)

Blood–brain barrier dysfunction in l-ornithine induced acute pancreatitis in rats and the direct effect of l-ornithine on cultured brain endothelial cells
por: Walter, Fruzsina R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g3fo15p3b82mepmgv8959nt7oa